Indeed, several case reports have linked acute renal injury to use of SGLT-2 inhibitors including one recent report of acute renal injury with biopsy proven acute tubular necrosis (ATN) associated with the use of dapagliflozin [6]. This evidence concerns the gene SLC5A2 and oculocutaneous albinism type 1.